HOME >> MEDICINE >> NEWS
New treatment boosts muscle function in myasthenia gravis

ST. PAUL, Minn. - A new type of treatment significantly reduces the severity of muscle weakness in myasthenia gravis (MG), giving hope for a new class of drugs to treat neurological disorders, according to a study published in the August 14, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

The drug, oral EN101antisense, inhibits the production of acetylcholine esterase, which is an important enzyme in the function of the neuromuscular junction, where nerves connect with muscles. Antisense is a synthetic, short segment of DNA that locks onto a strand of mRNA and blocks production of specific proteins.

This is the first time weve been able to show that antisense is effective and safe when taken orally for a neurological disease, said study author Zohar Argov, MD, with Hadassah Hebrew University Medical Center in Jerusalem and member of the American Academy of Neurology. Oral delivery of antisense has long been sought after since it is expected to improve patient compliance because daily injections wont be needed.

People with myasthenia gravis have increased fatigue and reduced strength in their voluntary muscles. Symptoms may also include a drooping eyelid, double vision, difficulty in swallowing, or slurred speech. Myasthenia gravis is believed to affect 20 out of every 100,000 people.

For the study, 16 people with myasthenia gravis were given daily doses of oral EN101 antisense for four days and monitored for one month. Four of the people later took the drug for a month. The study found that oral antisense reduced disease severity by an average of 46 percent, with patients experiencing improved muscle function, improved swallowing time and the disappearance of a drooping eyelid. Side effects reported during the study were dryness of eyes and mouth.

Experts say this discovery may have implications beyond myasthenia gravis. Oral antisense may become another mode of therapy in
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
13-Aug-2007


Page: 1 2

Related medicine news :

1. Spot on treatment for acne
2. New treatment effective in counteracting cocaine-induced symptoms
3. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
4. Preventive treatments in elderly people needs rethinking
5. Osteoporosis screening and treatment may be cost-effective for selected older men
6. Quality of treatment guidelines
7. Green tea holds promise as new treatment for inflammatory skin diseases
8. Many heart attack patients still not getting emergency clot-busting treatment
9. Electric fields have potential as a cancer treatment
10. New algorithm matches any tumor cells to best possible anti-cancer treatments
11. Screening for behavioral health first step to getting treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2019)... Mass. (PRWEB) , ... February 14, 2019 , ... ... raising money for the specific purpose of preparing its two disruptive spine portfolio companies, ... acquisition in the next 3-5 years. , The spine industry is consolidating evidenced ...
(Date:2/13/2019)... MIAMI (PRWEB) , ... February 14, 2019 , ... At ... 20,000 global entrepreneurs leapt to their feet and cheered as it was announced that ... Over the course of the last few years, the company has optimized its revolutionary ...
(Date:2/13/2019)... INDIANAPOLIS (PRWEB) , ... February 13, 2019 , ... ... playgrounds and in high school locker rooms. Unfortunately, bullies also frequent hospital units, ... colleagues and peers. , In this fully updated, second edition of What ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... SXSW ,’ four days of programming occurring at SXSW 2019 in Austin, ... organizations, industry and philanthropy to innovate, collaborate and activate initiatives aimed at ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... at the company’s annual member conference, Elevate 2019 at the Gaylord Rockies Resort ... and members to explore potential partnerships driving improved quality of patient care, reduced ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... , ... The Medicus Firm (TMF) has been selected to become a Strategic ... has been a vocal and enthusiastic supporter of ASPR, its members and its mission ... part of our DNA and becoming a strategic corporate partner of ASPR is an ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... the Justice Reinvestment Summit February 13-15, 2019, at the Salem Convention ... Criminal Justice Commission, will feature presentations, panels and workshops led by local and ...
(Date:2/13/2019)... ... ... Published in Music and Medicine an interdisciplinary journal, the article Use of ... No 1 (2019) is authored by Jay R. Lucker, Professor of Communication Sciences at ... , Some children cannot tolerate sounds so their systems “shut down” and stop ...
Breaking Medicine Technology:
Cached News: